Keyphrases
Zoledronic Acid
100%
Advanced Prostate Cancer
100%
Prostate Cancer Patients
100%
Intact Parathyroid Hormone (iPTH)
100%
Prognostic Role
100%
Confidence Interval
50%
Hazard Ratio
50%
Parathyroid Hormone Levels
50%
Placebo
33%
Acid Treatment
33%
Survival Outcomes
33%
Secondary Hyperparathyroidism
33%
Bone Metastasis
16%
Multivariate Analysis
16%
Negatively Associated
16%
Bone Turnover Markers
16%
Bisphosphonates
16%
Vitamin D
16%
Overall Survival
16%
Prospective Randomized Trial
16%
Normal Baselines
16%
Prognostic Factors
16%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
16%
Randomized Placebo-controlled Trial
16%
Prognostic Impact
16%
Interaction Test
16%
Pharmacology, Toxicology and Pharmaceutical Science
Zoledronic Acid
100%
Prostate Cancer
100%
Parathyroid Hormone
100%
Placebo
25%
Secondary Hyperparathyroidism
25%
Bone Metastasis
12%
Bisphosphonic Acid Derivative
12%
Overall Survival
12%
Vitamin D
12%
Placebo-Controlled Study
12%